Back
Telomir Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
TELO
Telomir Pharmaceuticals, Inc.
Last Price:
$1.28
Seasonality Move:
-24.18%
7 Day Trial
ALL ACCESS PASS
$
7
Telomir Pharmaceuticals, Inc. Stock Forecast
-
Is Telomir Pharmaceuticals, Inc. Stock Undervalued?The current Telomir Pharmaceuticals, Inc. [TELO] share price is $1.27. The Score for TELO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TELO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Telomir Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Telomir Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Telomir Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
telomirpharma.com
52-Week Data
52-Week High:
3.23
52-Week Low:
1.05
Prediction Charts
Market Cap:
42.2M
Price in USD:
1.27
Volume:
87.3K
Beta:
-0.71
Technical Analysis
SMA50:
1.25
SMA100:
1.31
SMA200:
1.42
52-Wk Change:
-59.42%
Stock Predictions
-
Is Telomir Pharmaceuticals, Inc. stock public?Yes, Telomir Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Telomir Pharmaceuticals, Inc. stock quote today?The Telomir Pharmaceuticals, Inc. stock price is 1.27 USD today.
-
How to buy Telomir Pharmaceuticals, Inc. stock online?You can buy Telomir Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 1.31 | 1.34 | 1.36 | 1.31 |
| Mar-17 | 1.31 | 1.35 | 1.35 | 1.30 |
| Mar-18 | 1.32 | 1.27 | 1.33 | 1.20 |
| Mar-19 | 1.26 | 1.32 | 1.32 | 1.23 |
| Mar-20 | 1.29 | 1.32 | 1.33 | 1.25 |
| Mar-23 | 1.30 | 1.28 | 1.30 | 1.23 |
| Mar-24 | 1.26 | 1.28 | 1.29 | 1.23 |
| Mar-25 | 1.27 | 1.33 | 1.33 | 1.26 |
| Mar-26 | 1.29 | 1.26 | 1.33 | 1.22 |
| Mar-27 | 1.25 | 1.25 | 1.26 | 1.21 |
| Mar-30 | 1.24 | 1.14 | 1.26 | 1.10 |
| Mar-31 | 1.18 | 1.30 | 1.30 | 1.16 |
| Apr-1 | 1.27 | 1.32 | 1.34 | 1.25 |
| Apr-2 | 1.31 | 1.27 | 1.33 | 1.25 |
Telomir Pharmaceuticals, Inc. Earnings
Data Unavailable
Telomir Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.
* Telomir Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.